Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in BRIDGEBIO PHARMA INC
DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.1M shares of BBIO (BRIDGEBIO PHARMA INC), worth $85.2M as of 2026-Q1. The position was decreased (-31.8% shares). BBIO represents 0.6% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$85.2M
Current Shares
1.1M
Total Value Change
+$33.3M
Total Shares Change
-353,887
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 1.1M |
-31.8% |
| $85.2M |
| 0.6% |
| $64.53 |
0 |
| 2025-Q4 | Increased | 1.7M | +1.1% | $128.6M | 0.9% | $75.48 | 43 |
| 2025-Q3 | Decreased | 1.7M | -1.7% | $86.3M | 0.6% | $51.96 | 0 |
| 2025-Q2 | Increased | 1.7M | +12.7% | $73M | 0.6% | $44.86 | 47 |
| 2025-Q1 | New | 1.5M | - | $51.9M | 0.5% | $35.11 | 57 |